Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc daily Stock Chart
GlaxoSmithKline plc
Index- P/E26.73 EPS (ttm)1.51 Insider Own0.20% Shs Outstand2.48B Perf Week-0.32%
Market Cap100.15B Forward P/E13.95 EPS next Y2.90 Insider Trans0.00% Shs Float2.45B Perf Month9.62%
Income3.71B PEG3.18 EPS next Q0.69 Inst Own10.60% Short Float0.40% Perf Quarter6.00%
Sales42.94B P/S2.33 EPS this Y184.00% Inst Trans-0.10% Short Ratio2.73 Perf Half Y-1.03%
Book/sh-0.04 P/B- EPS next Y-0.75% ROA2.60% Target Price40.43 Perf Year-2.03%
Cash/sh2.25 P/C18.00 EPS next 5Y8.40% ROE163.40% 52W Range34.52 - 44.53 Perf YTD14.01%
Dividend2.55 P/FCF29.90 EPS past 5Y-10.10% ROI22.90% 52W High-10.71% Beta0.81
Dividend %6.31% Quick Ratio0.40 Sales past 5Y2.70% Gross Margin69.10% 52W Low15.19% ATR0.57
Employees98462 Current Ratio0.60 Sales Q/Q0.70% Oper. Margin13.90% RSI (14)55.95 Volatility0.76% 1.28%
OptionableYes Debt/Eq- EPS Q/Q109.40% Profit Margin5.10% Rel Volume1.15 Prev Close40.44
ShortableYes LT Debt/Eq- EarningsMay 09 Payout179.20% Avg Volume3.60M Price39.76
Recom2.60 SMA201.07% SMA505.10% SMA2003.56% Volume2,168,825 Change-1.67%
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Sep-08-17Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-05-17Downgrade Citigroup Buy → Neutral
May-26-17Upgrade Berenberg Hold → Buy
Apr-05-17Upgrade Exane BNP Paribas Underperform → Neutral
Mar-09-17Initiated Liberum Buy
Mar-09-17Initiated Kepler Reduce
Oct-20-16Initiated Investec Buy
Sep-23-16Initiated Piper Jaffray Overweight
Jul-14-16Upgrade Jefferies Hold → Buy
Mar-30-16Upgrade Citigroup Neutral → Buy
Feb-26-16Initiated Cantor Fitzgerald Hold
Dec-09-15Upgrade BofA/Merrill Neutral → Buy
Dec-07-15Reiterated Argus Buy $52 → $48
Oct-20-15Upgrade Credit Suisse Underperform → Neutral
Sep-15-15Upgrade Exane BNP Paribas Underperform → Neutral
Apr-19-18 09:08AM  Sanofi to Divest European Generic Unit, Streamline Business Zacks
07:00AM  NeuroMetrix Reports Q1 2018 Financial Results GlobeNewswire
Apr-18-18 05:11PM  Experts query case for GlaxoSmithKline's new 3-in-1 lung drug Reuters
05:00PM  Landmark IMPACT Study Published in NEJM Shows Significant Benefits of Trelegy Ellipta for Patients with COPD Business Wire
10:37AM  GSK flags pharma M&A ambitions by poaching Roche deal-maker Reuters
09:24AM  GSK grabs Roche cancer expert to lead pharma pipeline deals Reuters
Apr-17-18 07:01PM  Glaxo, Novartis Join $4 Billion Gates-Led Push to Fight Malaria Bloomberg
Apr-16-18 02:00PM  Adaptimmune Presents MAGE-A4 and MAGE-A10 pre-clinical data at American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire
Apr-13-18 04:52PM  Mylan Denies Report It's Interested In Buying Merck KGaA's Consumer Biz Investor's Business Daily
03:20PM  Pharma Stock Roundup: NVS to Buy AveXis, PFE & ABBV's Drugs Succeed in Phase III Zacks
06:41AM  Glaxo to Sell Rare Disease Gene Therapies to Private Biotech Zacks
Apr-12-18 11:48AM  GSK divests its rare disease gene therapy portfolio American City Business Journals
09:51AM  GSK slims portfolio with sale of rare disease gene therapy drugs Reuters
09:35AM  Zacks Market Edge Highlights: Exxon, Diageo, GlaxoSmithKline, Micron and AMN Zacks
08:43AM  U.K. stocks waver as traders remain wary over Syria conflict MarketWatch
07:52AM  UK gene therapy firm Orchard plans stock offer after GSK deal Reuters
04:48AM  GSK slims portfolio with sale of rare disease gene therapy drugs Reuters
04:34AM  [$$] GSK sells rare disease gene therapy portfolio Financial Times
03:13AM  GSK divests rare disease gene therapy drugs to Orchard Therapeutics Reuters
Apr-11-18 10:37AM  Pfizer's Kidney Cancer Drug Misses Endpoint in Phase III Zacks
Apr-10-18 12:59PM  New GSK shingles vaccine off to strong start in key U.S. market Reuters
11:56AM  New GSK shingles vaccine off to strong start in key U.S. market Reuters
04:19AM  Novartis AG -- Moody's: $8.7 billion acquisition of AveXis strengthens Novartis's pipeline in gene therapy, but reduces financial flexibility Moody's
Apr-09-18 06:46AM  Novartis bets big on gene therapy with $8.7 billion AveXis deal Reuters
06:45AM  Why Novartis Is Paying $8.7 Billion for a Gene Therapy Developer Youve Never Heard Of Fortune
06:36AM  Novartis bets big on gene therapy with $8.7 bln AveXis deal Reuters
Apr-07-18 11:15AM  Better Buy: Eli Lilly and Co. vs. GlaxoSmithKline Motley Fool
Apr-06-18 10:11AM  Pharma Stock Roundup: LLY's Cyramza Shines in Cancer Study, PFE & AZN in Focus Zacks
09:27AM  4 Drug/Biotech Stocks to Buy Ahead of World Health Day Zacks
Apr-05-18 10:34AM  Lilly's Cyramza Shows Survival Benefit in Liver Cancer Study Zacks
09:08AM  3 Emerging Technologies Set to Transform the Pharma World Zacks
07:41AM  3 High-Yield Stocks That Have Bucked the Stock Market Correction Motley Fool
Apr-04-18 10:38AM  GlaxoSmithKline's Horlicks Up for Grabs: Who Will Snap It Up? Zacks
Apr-03-18 09:42AM  Biotech Stock Tests Buy Zone, Gets New Approval For Asthma Drug Relvar Ellipta Investor's Business Daily
Mar-30-18 09:43AM  O'Neill Properties to close soon on $50M+ deal for GSK property American City Business Journals
07:00AM  Better Buy: Celgene Corporation vs. Gilead Sciences Motley Fool
03:51AM  GlaxoSmithKline plc (LON:GSK): What Are The Future Prospects? Simply Wall St.
Mar-29-18 04:35PM  GS Mortgage Securities Trust 2017-GS5 -- Moody's Affirms Seven Classes of GSMS 2017-GS5 Moody's
06:06AM  Stark Wipes Out $235M Infringement Verdict Against Teva for Hypertension Drug ALM Media
Mar-28-18 05:21PM  Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict Reuters
05:18PM  UPDATE 2-Teva wins reversal of U.S. jury's $235 mln GSK drug patent verdict Reuters
11:39AM  Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict Bloomberg
11:32AM  GlaxoSmithKline Capital Inc. -- Moody's affirms GSK's A2 rating; stable outlook Moody's
10:18AM  Company News For Mar 28, 2018 Zacks
09:12AM  Glaxo (GSK) Buys Novartis' Stake in Consumer Healthcare JV Zacks
08:01AM  Novartis AG -- Moody's: Novartis's sale of joint venture stake could be credit positive, but uncertainty around use of proceeds and financial policies persist Moody's
12:34AM  [$$] GSK Buys Novartiss Stake in Health-Care Unit for $13 Billion The Wall Street Journal
12:05AM  [$$] Inside story about the past few weeks of dealmaking at GSK Financial Times
Mar-27-18 09:16PM  Nestle, other food groups likely suitors for GSK's Horlicks: sources Reuters
05:13PM  GSK and Chemours rise; Avon and ProPetro fall Associated Press
05:12PM  What Happened in the Stock Market Today Motley Fool
04:25PM  GlaxoSmithKline Buys Novartis Share Of Health Unit For $13 Billion Investor's Business Daily
02:40PM  Nestle, other food groups likely suitors for GSK's Horlicks: sources Reuters
12:13PM  FTSE 100 halt 4-session skid and end sharply higher MarketWatch
11:52AM  European stocks rebound to close higher after global trade concerns ease; GSK up almost 5% CNBC
11:32AM  Novartis's New CEO Has Cash and Momentum for an Overhaul Bloomberg
10:53AM  GlaxoSmithKline To Buy Novartis' Stake in Consumer Health Care JV For $13 Billion Benzinga
09:34AM  GSK buys out Novartis in $13 billion consumer healthcare shake-up Reuters
08:30AM  [$$] GSK Buys Novartis's Stake in Health-Care Unit for $13 Billion The Wall Street Journal
08:27AM  [$$] Walmsley still has a lot to do to bring GSK back to health Financial Times
08:15AM  Consolidated Research: 2018 Summary Expectations for BP p.l.c, Gerdau S.A, GlaxoSmithKline plc, Suncor Energy, TCF Financial, and BRF S.A Fundamental Analysis, Key Performance Indications GlobeNewswire
07:37AM  GSK's $13 Billion Novartis Deal Is Only Just the Start Bloomberg
07:31AM  GSK says very confident about consumer margin goal of at least 20 percent Reuters
07:13AM  Facebook, Novartis, GSK, Uber and Deutsche Bank - 5 Things You Must Know
06:57AM  GSK buys out Novartis in $13bln shake-up Reuters Videos
06:50AM  GSK Shares Surge on $13B Buyout Deal Struck With Novartis Investopedia
06:45AM  GSK says very confident about consumer margin goal of at least 20 percent Reuters
06:31AM  Five Things You Need to Know to Start Your Day Bloomberg
06:13AM  [$$] Stocks to watch: GSK, Ferguson, Superdry, H&M, Zurich Insurance Financial Times
06:13AM  4 Top-Ranked Drug/Biotech Stocks to Buy as Q1 Nears End Zacks
06:06AM  Glaxo to Buy Novartis JV Stake Bloomberg Video
04:24AM  [$$] Novartis sells stake in consumer business to GSK for $13bn Financial Times
02:56AM  Novartis sells joint venture stake to GSK for $13 billion Associated Press
01:54AM  [$$] GSK to Buy Novartis Stake in Consumer Health JV The Wall Street Journal
01:33AM  [$$] Novartis sells stake in joint venture to GSK for $13bn Financial Times
01:32AM  Novartis selling consumer-healthcare JV stake to GlaxoSmithKline MarketWatch
01:04AM  GSK Gets Full Control of Sensodyne Maker for $13 Billion Bloomberg
01:04AM  Glaxo to Buy Novartis Consumer-Venture Stake for $13 Billion Bloomberg
Mar-26-18 07:02PM  Open trade is ultimately in 'everyone's best interest,' Johnson & Johnson CEO says CNBC
03:44PM  Don't Worry, Pfizer Isn't Out of Options for Its Consumer Health Division Just Yet Motley Fool
10:19AM  Glaxo Drops Bid for Pfizer Unit, Shingrix Gains EU/Japan Nod Zacks
08:04AM  Is Pfizer's Best Option Now a Consumer Healthcare Spinoff? Motley Fool
04:53AM  Singapore pharma on recovery path after worst output in decades Reuters
12:11AM  [$$] Glaxo CEO Dispenses Bitter Pill to Fix R&D The Wall Street Journal
Mar-25-18 07:06PM  Singapore pharma on recovery path after worst output in decades Reuters
Mar-23-18 05:01PM  GSK Spikes After Dropping Bid For Pfizer's Over-The-Counter Unit Investor's Business Daily
04:22PM  Pharma Stock Roundup: ABBV's Rova-T Disappoints, J&J Unit Gets Buyout Offer Zacks
02:10PM  GSK pulls out of £14.2 billion race for Pfizer consumer assets Reuters
02:08PM  Pfizer is having a tough time selling its consumer health care business American City Business Journals
12:19PM  GSK pulls out of race for Pfizer consumer assets Reuters Videos
08:40AM  Glaxo's Boss Looks Ready to Loosen the Straitjacket Bloomberg
08:21AM  GSK withdraws from bidding for Pfizer's consumer health care unit American City Business Journals
07:59AM  GSK pulls out of $20 billion race for Pfizer consumer assets Reuters
07:52AM  GSK's two-drug HIV regimen wins European panel approval Reuters
07:38AM  What Are Analysts Saying About The Future Of GlaxoSmithKline plcs (NYSE:GSK)? Simply Wall St.
07:29AM  [$$] Stocks to watch: GSK, Indivior, Mitie, Just Eat, Smiths, M&S Financial Times
06:47AM  GSK Shares Jump After Pfizer Talks End Investopedia
06:10AM  [$$] GSK pulls out of auction to buy $20bn Pfizer business Financial Times
04:29AM  [$$] Glaxo Ends Talks for Pfizer Unit The Wall Street Journal
04:06AM  [$$] Glaxo Ends Talks for Pfizer Unit The Wall Street Journal
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerNov 06Buy14.00428,5715,999,9941,854,006Nov 07 07:42 PM